Company Filing History:
Years Active: 2005
Title: Innovations of Eun Young Han in Gene Therapy
Introduction
Eun Young Han is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of gene therapy, particularly in the development of retroviral vectors. His work focuses on addressing genetic disorders, showcasing the potential of innovative solutions in medicine.
Latest Patents
Eun Young Han holds a patent for the "Construction of high efficiency retroviral vector for gene therapy of Hunter syndrome." This invention provides a retroviral vector containing an iduronate-2-sulfatase (IDS) gene without a selective marker gene. The vector is constructed on a minimum sized MLV-based retroviral backbone, which does not contain any viral coding sequences but can still produce a high viral titer and drive a high level of gene expression. This advancement is crucial for effective gene therapy applications.
Career Highlights
Eun Young Han is currently associated with Viromed Limited, a company dedicated to innovative biopharmaceutical solutions. His work at Viromed Limited emphasizes the importance of research and development in the field of gene therapy. His contributions have the potential to improve treatment options for patients with genetic disorders.
Collaborations
Eun Young Han collaborates with talented individuals in his field, including Sunyoung Kim and Seung Shin Yu. These collaborations enhance the research environment and foster innovation in gene therapy.
Conclusion
Eun Young Han's work exemplifies the intersection of innovation and healthcare. His patent for a high-efficiency retroviral vector represents a significant step forward in gene therapy for Hunter syndrome. The advancements made by Han and his colleagues hold promise for the future of genetic medicine.